相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine-induced peripheral neuropathy in patients with lymphoma
David Azoulay et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-1. Follicular lymphoma (FL)
Koji Izutsu
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-5-diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS)
Ken Ohmachi
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia
Lang Li et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study
Nathalie K. Zgheib et al.
PHARMACOGENETICS AND GENOMICS (2018)
An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia
W. Stock et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Severe Vincristine-induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study
Marija Bosilkovska et al.
CLINICAL THERAPEUTICS (2016)
Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population
Angela Gutierrez-Camino et al.
PHARMACOGENETICS AND GENOMICS (2016)
Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
Barthelemy Diouf et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
Laurie H. Sehn et al.
BLOOD (2015)
Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review
Floortje Mols et al.
SUPPORTIVE CARE IN CANCER (2014)
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
David Cunningham et al.
LANCET (2013)
Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809
K. Ohmachi et al.
ANNALS OF ONCOLOGY (2011)
Phase II/III Study of R-CHOP-21 Versus R-CHOP-14 for Untreated Indolent B-Cell Non-Hodgkin's Lymphoma: JCOG 0203 Trial
Takashi Watanabe et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial
Christian Recher et al.
LANCET (2011)
Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma
Byung-Jo Kim et al.
QUALITY OF LIFE RESEARCH (2010)
Cep72 regulates the localization of key centrosomal proteins and proper bipolar spindle formation
Naoki Oshimori et al.
EMBO JOURNAL (2009)
Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients
Jamie L. Renbarger et al.
PEDIATRIC BLOOD & CANCER (2008)
Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy:: 9-year follow-up
MS Czuczman et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Chemotherapy-induced peripheral neuropathy
S Quasthoff et al.
JOURNAL OF NEUROLOGY (2002)
分享论文
